Laborie Medical Technologies announced that it acquired Pelvalon and its Eclipse non-surgical device for treating fecal incontinence.
Redwood City, California-based Pelvalon designed the FDA-cleared Eclipse system as a patient-controlled device for women suffering from fecal incontinence, according to a news release.
Portsmouth, N.H.-based Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).
Financial terms for the acquisition were not disclosed.
“Laborie’s mission every day is to operate as a world-class specialist medical company making and advancing technologies that preserve and restore human dignity,” Laborie president & CEO Michael Frazzette said in the release. “Our mission is well served by the addition of Eclipse to help pa…